National Health Investors (NHI) Reports Q4 Normalized FFO of $1.27

Go back to National Health Investors (NHI) Reports Q4 Normalized FFO of $1.27

Cantor Fitzgerald Remains Sidelined on National Health Investors (NHI) After Adjusting Estimates

February 21, 2017 6:55 AM EST

Cantor Fitzgerald reiterated a Neutral rating and $75.00 price target on National Health Investors (NYSE: NHI) after adjusting estimates. Cantor lowered 2017 normalized FFO estimates to $5.10 (from $5.17) compared with the $5.16 consensus and the $5.06-5.12 guidance. Cantor also initiated a 2018 normalized FFO estimate of $5.30 compared to consensus of... More

National Health Investors (NHI) Raises Quarterly Dividend 5.6% to $0.95; 5.1% Yield

February 17, 2017 5:47 AM EST

National Health Investors (NYSE: NHI) declared a quarterly dividend of $0.95 per share, or $3.8 annualized. This is a 5.6% increase from the prior dividend of $0.90.

The dividend will be payable on May 10, 2017, to stockholders of record on March 31, 2017, with an ex-dividend date of March 29,... More